-
Who we are
Who we are
We are a biotechnology company committed to helping address serious infectious diseases globally through the discovery and development of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
What we do
What we do
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
COVID-19 UPDATESNovavax has demonstrated its ability to quickly develop viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.
Investor Hub
Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.
Latest quarterly earnings
Latest investor presentation
Latest clinical presentation
Latest publications
Annual report
NASDAQ:NVAX
Latest press releasesEvents & presentationsReports & financialsSEC filingsStock details & analyst coverage
Past Events
Filter
Filter
Clear filterThursday, November 4, 2021
4:30pm - 5:30pm EDT
Wednesday, September 29, 2021
8:40am - 9:10am EDT
Monday, September 13, 2021 - Wednesday, September 15, 2021
7:00am - 1:00pm EDT
Friday, September 10, 2021
2:00pm - 2:30pm EDT
Thursday, September 9, 2021
4:10pm - 4:55pm EDT
Thursday, August 5, 2021
4:30pm EDT
Monday, June 14, 2021
8:30am EDT
Tuesday, June 1, 2021
1:30pm EDT
Monday, May 10, 2021
4:30pm EDT
Tuesday, March 9, 2021
7:00am EST
Monday, March 1, 2021
4:30pm EST
Thursday, January 28, 2021
4:30pm EST
Get notifications for investor updates
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.
Investor inquiries
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at [email protected]
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.
![Graph icon](/sites/default/files/images/Investors-Abstract.png)